AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Freely Filtered 028: Finerenone for diabetic kidney disease
Freely Filtered, a NephJC Podcast
Egfr
I think if someone were being doubles advocate here, it would be that there's a different outcome that you're comparing to this well. And I'm not arguing to compare. So also in figure one, you have the key secondary composite outcome of death from cardiovascular causes or hospitalization from heart failure. This composite occurred in 13% of patients with finarinone versus 14.8% of patients on placebo,. It also reached statistical significance with a P-value of 0.03. Let's not forget as GFR is falling, your cardiovascular risk is going way up.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode